SARS-CoV-2 infection rate very high amongst UK strictly-Orthodox Jewish community
SARS-CoV-2 infection rate very high amongst UK strictly-Orthodox Jewish community 2 February 2021 London School of Hygiene & Tropical Medicine London School of Hygiene & Tropical Medicine https://lshtm.ac.uk/themes/custom/lshtm/images/lshtm-logo-black.png
New estimates suggest more than 60% of the community may have had COVID-19 in 2020 Share
The UK strictly-Orthodox Jewish community experienced a very high burden of SARS-CoV-2 infection during 2020, according to a new preliminary study by the London School of Hygiene & Tropical Medicine (LSHTM).
The study, which is yet to be peer reviewed, was conducted with partners University College London’s Great Ormond Street Institute of Child Health and the Medical Advocacy and Referral Service (MARS), an organisation supporting the healthcare needs of strictly-Orthodox Jewish communities.
The Lancet: Russian Sputnik V Vaccine Shown Over 90 Percent Effective russiaherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from russiaherald.com Daily Mail and Mail on Sunday newspapers.
Russia’s
Sputnik V vaccine was 91.6% effective in preventing people from developing COVID-19, according to peer-reviewed results from its late-stage clinical trial published in The Lancent international medical journal on Tuesday.
Scientists said the Phase III trial results meant the world had another effective weapon to fight the deadly pandemic and justified to some extent Moscow’s decision to roll out the vaccine before final data had been released.
The results, collated by the Gamaleya Institute in Moscow that developed and tested the vaccine, were in line with efficacy data reported at earlier stages of the trial, which has been running in Moscow since September.
BBC News
By James Gallagher
The Oxford-AstraZeneca vaccine could lead to a substantial fall in the spread of the virus, say scientists.
The impact of Covid vaccines on transmission has been a crucial unknown that will dramatically shape the future of the pandemic.
The study, which has not been formally published, also showed the vaccine remained effective while people waited for a second dose.
It was 76% effective during the three months after the first shot.
The impact on transmission is critical.
If a vaccine only stops you getting severely ill, but you can still catch and pass on the virus, then everyone will need to be immunised to be protected.
Russia s Sputnik V vaccine 92% effective, finds peer-reviewed late-stage trial
Empty vials of the second dose of the Sputnik V (Gam-COVID-Vac) vaccine are pictured at the San Martin hospital, in La Plata, on the outskirts of Buenos Aires, Argentina on January 21, 2021. File Photo: Reuters/ Agustin Marcarian Reuters, Moscow Reuters, Moscow
Scientists gave Russia s Sputnik V vaccine the green light on Tuesday saying it was almost 92% effective in fighting Covid-19 based on peer-reviewed late-stage trial results published in The Lancet international medical journal.
Experts said the Phase III trial results meant the world had another effective weapon to fight the deadly pandemic and justified to some extent Moscow s decision to roll out the vaccine before final data had been released.